NAAT tests, including PCR tests, are more likely to detect the virus, and are considered the “gold standard” for COVID-19 ...

Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, announces the commercial launch of QAPs™ quality assessment products and ...

Global Influenza Diagnostics Market OverviewThe global influenza diagnostics market is projected to expand at a CAGR of 5–8% over the next five years. Market growth is fueled by the rising prevalence ...

As the spread of dengue and malaria once again bedevils people in the port city, diagnostic tests and platelet treatments have become unaffordable for the public. As a result, small laboratories are ...

This study provides useful insights into addressing the question of whether the prevalence of autoimmune disease could be driven by sex differences in the T cell receptor (TCR) repertoire, correlating ...

Chennai, Dec. 10 -- Highlights: ...

The COVID-19 Treatment QuickStart Consortium worked with governments in seven low- and middle-income countries (LMICs), Ghana ...

Obe-cel demonstrates high remission rates in pediatric patients with high-risk r/r B-ALL with overall response rate (ORR) of 95.5%; low rates of ...

DM had rejected the claim citing absence of a valid COVID-19 test report and relying on two doctors’ statements disputing the antigen-positive slip ...

Uniogen's progress toward clinical commercialization aligns with larger internal goals of bringing cancer diagnostics to market, with a specific focus on women's health.

Although the readout was only from four multiple myeloma patients, attendees at the meeting wondered at how far the CAR T-cell therapy field has come.

Northwestern scientists have created the fastest-ever hepatitis C diagnostic, delivering accurate results in only 15 minutes.